Markets & Industries
    Stock Market Today:
    March 27, 2015
     CurrentToday's Change
    NASDAQ4,880.0016.640.34%
    S&P 5002,058.472.320.11%
    DOW17,680.602.370.01%
    Russell 20001,237.295.300.43%
    NASDAQ
    All data as of 2:52 PM Mar 27, 2015. Delayed at least 15 minutes
    Featured Commentaries
    StockCommentary
    Drug Roundup: March 27, 2015
    Michael Ratty  |  03/27/2015
    There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve. Companies mentioned in this review include Valeant Pharmaceuticals (VRX), Salix Pharmaceuticals (SLXP), Endo International (ENDP), and Biogen (BIIB).
    Market Daily Updates
    Stock Market Today: March 27, 2015
    Harvey S. Katz, CFA, Matthew E. Spencer, CFA, Adam Rosner  |  03/27/2015
    The U.S. stock market pressed higher earlier, pulled back briefly, but stabilized into the lunch hour. As we move past noon in New York, there is still a tentative quality to the session. The Dow Jones Industrials are up one point; the broader S&P 500 Index is ahead two points; and the NASDAQ, which is assuming the leadership role, is advancing 10 points.
    Market Daily Updates
    Stock Market Today: March 26, 2015
    Harvey S. Katz, Matthew E. Spencer, Simon E. Shnayder, Adam Rosner  |  03/26/2015
    The U.S. stock market spent much of the day on a rollercoaster ride. The major averages headed sharply lower this morning, spent the afternoon in recovery mode, moved briefly into positive territory, only to pull back again later in the session. At the close of trading, the Dow Jones Industrial Average was down 40 points; the broader S&P 500 Index was off five points; and the NASDAQ was lower by 13 points. The majority of stocks lost ground today, as declining issues outnumbered advancers by a healthy margin on the NYSE.
    StockCommentary
    The Dogs Of The Dow Are A Bit Under The Weather
    Kenneth Nugent  |  03/26/2015
    Thus far in 2015, the performance of the Dogs of the Dow has not been particularly inspiring, with the 10 highest-yielding Dow components at the start of the year up 5.0% in February, versus a 5.7% increase in the overall Dow and a 6.1% jump in the remaining 20 companies that make up the Dow Jones Industrial Average.
    StockHighlights
    Using A Value Line Report: Apple Finally Enters the Garden of Credence
    Simon Shoucair  |  03/25/2015
    Apple, Inc. has arguably become one of the most influential and innovative manufacturers in the global personal technology market, if not the most recognizable name in modern technology to date. Indeed, among the many newsworthy developments we will discuss in this review, the bit that commands the most attention of late is undoubtedly the tech titan’s long-awaited debut on the Dow Jones Index, a nod which many would contend has given the equity an overdue badge of credence that elevates it among the investment elite. This review will offer some insight regarding the benefits and caveats to joining the Dow, as well as analyzing the Value Line page to demonstrate the stock’s investment merits and potential pitfalls.
    • Video Commentary
      Value Line Website Tutorial: The New Digital Stock Report

      An unexpected error has occurred.

      The appropriate people have been notified of this error, and will be working to correct the problem as soon as possible.Thank you for your patience.
      • Research Notes
        Mar 27, 2015
        Please sign in to read more.
        Mar 27, 2015
        Please sign in to read more.
        Mar 27, 2015
        Please sign in to read more.
        Mar 27, 2015
        Please sign in to read more.
        Mar 27, 2015
        Please sign in to read more.

        An unexpected error has occurred.

        The appropriate people have been notified of this error, and will be working to correct the problem as soon as possible.Thank you for your patience.